skyrizi.com — August 2026 traffic, keywords & AI visibility

# SKYRIZI Official Site

## About
SKYRIZI is a prescription biologic therapy developed to treat moderate to severe plaque psoriasis, active psoriatic arthritis, and moderate to severe Crohn’s disease and ulcerative colitis. The treatment works by targeting interleukin-23, a key driver of inflammation that fuels these chronic immune-mediated conditions. Patients receive the medication through convenient self-administered injections on a dosing schedule that typically starts with starter doses followed by maintenance every eight or twelve weeks. The company behind SKYRIZI focuses on delivering clear skin results, joint symptom relief, and sustained remission for people living with these lifelong diseases. Clinical studies have shown that many patients achieve significant skin clearance and reduced joint pain within weeks of starting therapy. Beyond the medication itself, SKYRIZI provides comprehensive support programs that include cost assistance, injection training, and ongoing patient education resources. The brand works closely with dermatologists, rheumatologists, and gastroenterologists to ensure appropriate patient selection and monitoring. Real-world evidence continues to demonstrate long-term safety and effectiveness across diverse patient populations. SKYRIZI’s parent organization invests heavily in research to expand indications and improve formulation convenience. The